Retail & Wholesale » Retail | New Ray Medicine International Holding Ltd.

New Ray Medicine International Holding Ltd. | Cash Flow

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
28,724.00
43,858.00
30,063.00
13,708.00
94,389.00
39,197
Depreciation, Depletion & Amortization
1,410.00
1,173.00
2,587.00
7,628.00
3,838.00
3,820
Other Funds
474.00
-
-
-
-
39,349
Funds from Operations
22,510.00
32,872.00
19,524.00
3,646.00
7,304.00
3,668
Changes in Working Capital
1,432.00
17,444.00
20,896.00
16,516.00
114,101.00
55,388
Net Operating Cash Flow
21,078.00
15,428.00
1,372.00
20,162.00
106,797.00
59,056
Capital Expenditures
2,536.00
1,986.00
62,520.00
18,278.00
78.00
Sale of Fixed Assets & Businesses
525.00
-
16.00
-
-
Purchase/Sale of Investments
-
19,583.00
181,376.00
18,083.00
194,369.00
Net Investing Cash Flow
2,011.00
21,569.00
256,481.00
23,760.00
194,447.00
Cash Dividends Paid - Total
-
20,000.00
-
-
-
Issuance/Reduction of Debt, Net
12,000.00
-
-
17,321.00
16,904.00
Net Financing Cash Flow
47,390.00
64,854.00
166,203.00
61,976.00
315,296.00
Net Change in Cash
67,120.00
57,533.00
94,147.00
14,804.00
18,596.00
Free Cash Flow
18,542.00
13,442.00
5,277.00
25,376.00
106,875.00
Other Sources
-
-
-
12,601.00
-
Change in Capital Stock
59,864.00
84,854.00
166,203.00
44,655.00
332,200.00
Exchange Rate Effect
663.00
1,180.00
2,497.00
3,250.00
4,544.00
Other Uses
-
-
12,601.00
-
-

About New Ray Medicine International Holding

View Profile
Address
B-C, 37th Floor
Hangzhou Zhejiang 311112
China
Employees -
Website http://www.newraymedicine.com
Updated 07/08/2019
New Ray Medicine International Holding Ltd. is an investment company, which engages in the distribution and trading of pharmaceutical products. It operates through the following business segments: Injection Drugs; Capsule and Granule Drugs; Tablet Drugs; Marketing and Promotion Services; and Others. The Injection Drugs segment includes the trading of injection drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.